SynchronyNomura

Synchrony vs Nomura

US consumer finance partner powering retail and healthcare credit vs Publicly traded company. Which is the better buy for your portfolio in July 2026? Plain-English answer below.

Synchrony Financial issues store credit cards and consumer installment loans through retail partnerships while Nomura advises on deals, trades securities, and manages assets across global capital mark...

Why It’s Moving

Synchrony

SYF is drawing renewed attention as analysts keep pointing to upside, even without a fresh catalyst this week.

  • Analysts still see a double-digit upside profile for Synchrony Financial, with recent forecasts clustering in the mid-$80s to around $90 and implying roughly 20% to 30% upside from the latest share price. That keeps investor attention on whether the company can keep delivering enough earnings power to justify the re-rating.
  • The stock’s outlook is being supported more by analyst confidence than by a fresh company-specific catalyst in the last week. A broad consensus of Buy ratings suggests the market is still focused on Synchrony’s resilient consumer credit franchise and its ability to translate stable loan demand into profits.
  • In the absence of major new earnings or headline news over the past seven days, SYF is moving largely with the broader financials and consumer credit backdrop. Investors are watching for signs that credit quality, borrowing trends, and interest-rate expectations will either help margins or pressure delinquencies.
Sentiment:
⚖️Neutral

Investment Analysis

Pros

  • Synchrony Financial delivered robust earnings in Q3 2025, significantly exceeding analyst expectations for both EPS and revenue.
  • The company maintains a strong return on tangible common equity and has expanded its partnerships with major retailers, supporting loan growth.
  • Synchrony's credit quality remains solid, with better-than-expected delinquency rates and net charge-offs, reducing loan loss provisions.

Considerations

  • Loan growth has started to slow as consumers become more cautious, limiting near-term expansion potential.
  • Elevated funding costs and persistent high interest rates are pressuring net interest margins.
  • The stock's valuation already reflects much of its credit stability, leaving limited upside if economic conditions worsen.

Pros

  • Nomura Holdings benefits from a diversified business model spanning retail, wholesale, and asset management operations.
  • The company maintains a strong capital position and has demonstrated resilience in volatile market conditions.
  • Nomura continues to invest in digital transformation and international expansion, supporting long-term growth prospects.

Considerations

  • Nomura's profitability remains sensitive to global market volatility and interest rate fluctuations.
  • The company faces stiff competition in both domestic and international markets, constraining margin expansion.
  • Recent regulatory scrutiny and compliance costs have increased operational risks and expenses.

Synchrony (SYF) Next Earnings Date

Synchrony Financial (SYF) is expected to report its next earnings on July 21, 2026, based on its typical mid-to-late July reporting pattern. The release will cover second-quarter 2026 results. As of this date, that is the most likely next earnings date, although the company had not confirmed it in advance.

Buy SYF or NMR in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

SYF
SYF$74.58
vs
NMR
NMR$9.74
Buy SYF